Italy Artificial Organs & Bionic Implants Market Size (2024 - 2029)

The Italy artificial organs and bionic implants market is anticipated to experience growth over the forecast period, driven by factors such as an increased incidence of disabilities, organ failures, and a scarcity of donors. The market's expansion is further supported by technological advancements and strategic initiatives from key players, including product development and collaborations. Despite the positive outlook, challenges such as high costs and potential compatibility issues may hinder market growth. The market's recovery and growth trajectory have been influenced by the COVID-19 pandemic, which initially disrupted demand but later saw a return to pre-pandemic levels due to prioritized vaccination and safety measures for transplant recipients.

Market Size of Italy Artificial Organs & Bionic Implants Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Italy Artificial Organs & Bionic Implants Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 2.00 %
Market Concentration Medium

Major Players

Italy Artificial Organs & Bionic Implants Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Italy Artificial Organs & Bionic Implants Market Analysis

The Italy Artificial Organs & Bionic Implants Market is expected to register a CAGR of 2% during the forecast period.

The initial stages of the COVID-19 pandemic significantly impacted the Italy artificial organs & bionic implants market. For instance, according to an article published by the National Library of Medicine, in July 2022, during the first four weeks of the COVID-19 pandemic in Italy, there was a 25% reduction in the total organ procured. Less availability of ICU beds for both transplant recipients and donors negatively impacted total donation activity and ultimately resulted in fewer transplants. This led to a reduction in demand for artificial organs & bionic implants. However, most countries, including Italy, adopted vaccination prioritization processes, including priority for solid organ transplantation recipients to reduce the infection risk. For instance, according to the above source, transplantation rates returned to pre-pandemic levels, novel treatments were identified, and vaccination of solid organ transplantation recipients was prioritized. Approximately 80% of solid organ transplantation recipients in Italy received at least a vaccine dose by October 2021. Thus, with an increased initiative for the safety of solid organ transplantation recipients, the market started to witness a pre-pandemic level growth rate gradually.

The major factors driving the market growth are increased incidence of disabilities, organ failures and scarcity of donors, high road accidents leading to amputations, and technological advancements in artificial organs and bionics. For instance, in the article published by Istat on Road accidents in Italy, the number of accidents per 100 thousand inhabitants was higher than the national average (256.9) in 7 regions (from 473.6 in Liguria to 259.1 in Lombardy region), lower in Calabria (139.6), Molise (143.9) and Campania ( 160.7) in 2021. Thus, the high burden of road accidents in the country is expected to increase the chances of amputation, thereby fuelling the growth of the market studied over the forecast period.

Furthermore, strategic initiatives by key players such as various product development, mergers, acquisitions, and collaboration are likely to accelerate market growth. For instance, in September 2022, Pixium Vision SA announced the report of the completion of patient enrollment in the PRIMAvera pivotal trial in atrophic dry age-related macular degeneration (dry AMD), also known as Geographic Atrophy. The study was initiated in Q4 2020 in France, where the first patient was enrolled in December 2020. Pixium Vision has since established additional clinical sites and implanted patients in France, Germany, the UK, the Netherlands, and Italy. Such development is expected to drive the growth of the market in Italy over the forecast period.

However, expensive procedures and the risk of compatibility issues and malfunctions are expected to restrain the market growth.

Italy Artificial Organs & Bionic Implants Industry Segmentation

As per the scope of the report, artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. Artificial Organs are implemented in human bodies with living tissue, which can perform the original function of human body parts. Bionics refers to the replacement or improvement of body parts by mechanical kinds. The Italy Artificial Organs & Bionic Implants Market is Segmented By Type (Artificial Organs (Artificial Heart, Artificial Kidney, Cochlear Implants, and Other Organ Types), and Bionics(Ear Bionics, Orthopedic Bionic, Cardiac Bionics, Eye Bionics and Others)). The report offers the value (in USD million) for the above segments.

By Type
Artificial Organ
Artificial Heart
Artificial Kidney
Cochlear Implants
Other Organ Types
Bionics
Ear Bionics
Orthopedic Bionic
Cardiac Bionics
Eye Bionics
Others
Need A Different Region Or Segment?
Customize Now

Italy Artificial Organs & Bionic Implants Market Size Summary

The Italy artificial organs and bionic implants market is poised for moderate growth, driven by factors such as the increasing incidence of disabilities, organ failures, and the scarcity of donors. The market experienced initial setbacks due to the COVID-19 pandemic, which led to a reduction in organ procurement and transplantation activities. However, with the prioritization of vaccination for solid organ transplantation recipients and the resumption of transplantation rates to pre-pandemic levels, the market began to recover. Technological advancements in artificial organs and bionics, along with strategic initiatives by key players, are expected to further propel market growth. Innovations such as the bionic eye implant and developments in eye and kidney bionics are anticipated to drive segmental growth, addressing the rising demand due to increased vision impairment and kidney diseases among the aging population.

The market landscape is moderately competitive, with several companies operating in Italy, including Abiomed Inc., LivaNova PLC, Cochlear Ltd, Berlin Heart, and Medtronic. Strategic collaborations, such as the kidney exchange program between the United States and Italy, highlight the global interconnectedness and potential for market expansion. Despite the promising growth prospects, challenges such as the high cost of procedures and potential compatibility issues may hinder market progress. Nonetheless, the ongoing innovations and strategic partnerships are likely to sustain the market's growth trajectory over the forecast period, addressing the evolving healthcare needs of the Italian population.

Explore More

Italy Artificial Organs & Bionic Implants Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increased Incidence of Disabilities, Organ Failures and Scarcity of Donors

      2. 1.2.2 High Incidence of Road Accidents Leading to Amputations

      3. 1.2.3 Technological Advancements in the Artificial Organ and Bionics

    3. 1.3 Market Restraints

      1. 1.3.1 Expensive Procedures

      2. 1.3.2 Risk of Compatibility Issues and Malfunctions

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Type

      1. 2.1.1 Artificial Organ

        1. 2.1.1.1 Artificial Heart

        2. 2.1.1.2 Artificial Kidney

        3. 2.1.1.3 Cochlear Implants

        4. 2.1.1.4 Other Organ Types

      2. 2.1.2 Bionics

        1. 2.1.2.1 Ear Bionics

        2. 2.1.2.2 Orthopedic Bionic

        3. 2.1.2.3 Cardiac Bionics

        4. 2.1.2.4 Eye Bionics

        5. 2.1.2.5 Others

Italy Artificial Organs & Bionic Implants Market Size FAQs

The Italy Artificial Organs & Bionic Implants Market is projected to register a CAGR of 2% during the forecast period (2024-2029)

Cochlear Ltd, Abiomed Inc., Berlin Heart, Össur and LivaNova, PLC are the major companies operating in the Italy Artificial Organs & Bionic Implants Market.

Italy Artificial Organs & Bionic Implants Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)